Browse > Article
http://dx.doi.org/10.3961/jpmph.17.097

One Health Perspectives on Emerging Public Health Threats  

Ryu, Sukhyun (Division of Infectious Disease Control, Gyeonggi Provincial Government)
Kim, Bryan Inho (Department of Epidemiology and Medical Informatics, School of Public Health, Korea University)
Lim, Jun-Sik (Disease Diagnostic Team, Gyeonggi Livestock and Veterinary Service)
Tan, Cheng Siang (Centre for Tropical and Emerging Diseases, Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak)
Chun, Byung Chul (Department of Epidemiology and Medical Informatics, School of Public Health, Korea University)
Publication Information
Journal of Preventive Medicine and Public Health / v.50, no.6, 2017 , pp. 411-414 More about this Journal
Abstract
Antimicrobial resistance and emerging infectious diseases, including avian influenza, Ebola virus disease, and Zika virus disease have significantly affected humankind in recent years. In the premodern era, no distinction was made between animal and human medicine. However, as medical science developed, the gap between human and animal science grew deeper. Cooperation among human, animal, and environmental sciences to combat emerging public health threats has become an important issue under the One Health Initiative. Herein, we presented the history of One Health, reviewed current public health threats, and suggested opportunities for the field of public health through better understanding of the One Health paradigm.
Keywords
One health; Zoonoses; Antibiotic resistance; Infectious disease; Korea;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Taylor LH, Latham SM, Woolhouse ME. Risk factors for human disease emergence. Philos Trans R Soc Lond B Biol Sci 2001;356(1411):983-989.   DOI
2 World Health Organization. One health; 2017 [cited 2017 Oct 23]. Available from: http://www.who.int/features/qa/one-health/en/.
3 Parent A. Felix Vicq d'Azyr: anatomy, medicine and revolution. Can J Neurol Sci 2007;34(1):30-37.   DOI
4 Foege WH. One world, one health, can we muddle through? [cited 2017 Jun 29]. Available from: http://www.oneworldonehealth.org/sept2004/presentations/eve_foege.html.
5 World Bank. People, pathogens, and our planet. Volume 1: towards a one health approach for controlling zoonotic diseases; 2010 [cited 2017 Oct 23]. Available from: http://siteresources.worldbank.org/INTARD/Resources/PPP_Web.pdf.
6 US Food and Drug Administration. The national antimicrobial resistance monitoring system; 2015 [cited 2017 Oct 23]. Available from: https://www.fda.gov/animalveterinary/safetyhealth/antimicrobialresistance/nationalantimicrobialresistancemonitoringsystem/.
7 Casewell M, Friis C, Marco E, McMullin P, Phillips I. The European ban on growth-promoting antibiotics and emerging consequences for human and animal health. J Antimicrob Chemother 2003;52(2):159-161.   DOI
8 Ryu S, Head MG, Kim BI, Hwang J, Cho EH. Are we investing wisely? A systematic analysis of nationally funded antimicrobial resistance projects in Republic of Korea, 2003-2013. J Glob Antimicrob Resist 2016;6:90-94.   DOI
9 Yu Z, Gao X, Wang T, Li Y, Li Y, Xu Y, et al. Fatal H5N6 avian influenza virus infection in a domestic cat and wild birds in China. Sci Rep 2015;5:10704.   DOI
10 Mylne AQ, Pigott DM, Longbottom J, Shearer F, Duda KA, Messina JP, et al. Mapping the zoonotic niche of Lassa fever in Africa. Trans R Soc Trop Med Hyg 2015;109(8):483-492.   DOI